PhytoHealth Corporation (TPE:4108)
Taiwan
· Delayed Price · Currency is TWD 13.05
-0.60 (-4.40%)
Mar 9, 2026, 1:35 PM CST
PhytoHealth Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 134.58 | 153.56 | 162.49 | 135.47 | 168.94 | Upgrade
|
| Revenue Growth (YoY) | -12.36% | -5.49% | 19.95% | -19.81% | 84.01% | Upgrade
|
| Cost of Revenue | 93.28 | 89.56 | 94.85 | 78.43 | 90.62 | Upgrade
|
| Gross Profit | 41.29 | 64.01 | 67.64 | 57.03 | 78.31 | Upgrade
|
| Selling, General & Admin | 89.72 | 95.68 | 96.73 | 94.23 | 90.06 | Upgrade
|
| Research & Development | 126.15 | 128.51 | 92.59 | 119.52 | 120.47 | Upgrade
|
| Operating Expenses | 215.87 | 224.19 | 189.32 | 213.7 | 210.42 | Upgrade
|
| Operating Income | -174.58 | -160.18 | -121.68 | -156.66 | -132.11 | Upgrade
|
| Interest Expense | -0.38 | -0.34 | -0.34 | -0.31 | -0.41 | Upgrade
|
| Interest & Investment Income | 18.04 | 45.87 | 41.19 | 36.31 | 29.66 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.11 | 0.2 | 1.61 | 2.09 | Upgrade
|
| Other Non Operating Income (Expenses) | 46.8 | 6.09 | 6.58 | 4.27 | 5.29 | Upgrade
|
| EBT Excluding Unusual Items | -110.11 | -108.45 | -74.05 | -114.78 | -95.48 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 0.1 | 0.07 | 0.07 | 0.04 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.19 | -0.17 | -0.01 | -0.08 | Upgrade
|
| Other Unusual Items | - | - | 0 | - | - | Upgrade
|
| Pretax Income | -110.11 | -108.53 | -74.15 | -114.72 | -95.52 | Upgrade
|
| Income Tax Expense | -0.02 | - | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -110.1 | -108.53 | -74.15 | -114.72 | -95.52 | Upgrade
|
| Minority Interest in Earnings | 51.9 | 35.03 | 27.03 | 35.31 | 17.8 | Upgrade
|
| Net Income | -58.2 | -73.5 | -47.12 | -79.41 | -77.72 | Upgrade
|
| Net Income to Common | -58.2 | -73.5 | -47.12 | -79.41 | -77.72 | Upgrade
|
| Shares Outstanding (Basic) | 201 | 199 | 199 | 199 | 196 | Upgrade
|
| Shares Outstanding (Diluted) | 201 | 199 | 199 | 199 | 196 | Upgrade
|
| Shares Change (YoY) | 1.04% | - | - | 1.49% | 19.61% | Upgrade
|
| EPS (Basic) | -0.29 | -0.37 | -0.24 | -0.40 | -0.40 | Upgrade
|
| EPS (Diluted) | -0.29 | -0.37 | -0.24 | -0.40 | -0.40 | Upgrade
|
| Free Cash Flow | -45.26 | -54.85 | -59.68 | -61.55 | -81.46 | Upgrade
|
| Free Cash Flow Per Share | -0.23 | -0.28 | -0.30 | -0.31 | -0.42 | Upgrade
|
| Gross Margin | 30.68% | 41.68% | 41.63% | 42.10% | 46.36% | Upgrade
|
| Operating Margin | -129.73% | -104.31% | -74.88% | -115.65% | -78.20% | Upgrade
|
| Profit Margin | -43.25% | -47.86% | -29.00% | -58.62% | -46.00% | Upgrade
|
| Free Cash Flow Margin | -33.63% | -35.72% | -36.73% | -45.44% | -48.22% | Upgrade
|
| EBITDA | -125.51 | -118.32 | -79.16 | -114.85 | -90.16 | Upgrade
|
| EBITDA Margin | -93.26% | -77.05% | -48.72% | -84.78% | -53.37% | Upgrade
|
| D&A For EBITDA | 49.07 | 41.87 | 42.52 | 41.82 | 41.95 | Upgrade
|
| EBIT | -174.58 | -160.18 | -121.68 | -156.66 | -132.11 | Upgrade
|
| EBIT Margin | -129.73% | -104.31% | -74.88% | -115.65% | -78.20% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.